E Vericel
Overview
Explore the profile of E Vericel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guichardant M, Chen P, Liu M, Lo Van A, Jouvene C, Bernoud-Hubac N, et al.
Prostaglandins Leukot Essent Fatty Acids
. 2020 Oct;
162:102185.
PMID: 33038835
Double lipoxygenation of polyunsaturated fatty acids having at least three methylene-interrupted double bonds can be made by two lipoxygenases, e.g. 5- and 12-LOX, or 15-LOX only, followed by reduction of...
2.
Lagarde M, Calzada C, Jouvene C, Bernoud-Hubac N, Letisse M, Guichardant M, et al.
Prog Lipid Res
. 2015 Oct;
60:41-9.
PMID: 26484703
Synthesis of bioactive oxygenated metabolites of polyunsaturated fatty acids and their degradation or transformation products are made through multiple enzyme processes. The kinetics of the enzymes responsible for the different...
3.
Vericel E, Colas R, Calzada C, Le Q, Feugier N, Cugnet C, et al.
Thromb Haemost
. 2015 Apr;
114(2):289-96.
PMID: 25832443
Platelets from patients with type 2 diabetes are characterised by hyperactivation and high level of oxidative stress. Docosahexaenoic acid (DHA) may have beneficial effects on platelet reactivity and redox status....
4.
Lagarde M, Hachem M, Bernoud-Hubac N, Picq M, Vericel E, Guichardant M
Prostaglandins Leukot Essent Fatty Acids
. 2014 Mar;
92:63-5.
PMID: 24582148
1-acetyl,2-docosahexaenoyl-glycerophosphocholine (AceDoPC) has been made to prevent docosahexaenoyl (DHA) to move to the sn-1 position as it rapidly does when present in 1-lyso,2-docosahexaenoyl-GPC (lysoPC-DHA), an efficient DHA transporter to the...
5.
Lagarde M, Calzada C, Guichardant M, Vericel E
Prostaglandins Leukot Essent Fatty Acids
. 2012 Apr;
88(1):49-52.
PMID: 22520055
Docosahexaenoic acid (DHA) is known as a major nutrient from marine origin. Considering its beneficial effect in vascular risk prevention, the effect of DHA on blood components, especially platelets, will...
6.
Guichardant M, Chen P, Liu M, Calzada C, Colas R, Vericel E, et al.
Chem Phys Lipids
. 2011 Jun;
164(6):544-8.
PMID: 21703251
Because of their high degree of unsaturation, polyunsaturated fatty acids (PUFA) in mammals, with mainly 18, 20 and 22 carbons, can easily be autooxidized, and converted into many oxidized derivatives...
7.
Picq M, Chen P, Perez M, Michaud M, Vericel E, Guichardant M, et al.
Mol Neurobiol
. 2010 Apr;
42(1):48-51.
PMID: 20422316
Docosahexaenoic acid (DHA), the end-product of the metabolism of omega-3 family fatty acids, is the main polyunsaturated fatty acid of the brain, but its accumulation is incompletely understood. This paper...
8.
Lagarde M, Chen P, Vericel E, Guichardant M
Prostaglandins Leukot Essent Fatty Acids
. 2010 Mar;
82(4-6):227-30.
PMID: 20207119
Polyunsaturated fatty acids of nutritional value may affect cell functions after their release from cell lipid storage sites, especially phospholipids, and specific oxygenation by cyclooxygenases, lipoxygenases and cytochrome P(450). The...
9.
Chen P, Fenet B, Michaud S, Tomczyk N, Vericel E, Lagarde M, et al.
FEBS Lett
. 2009 Oct;
583(21):3478-84.
PMID: 19818771
Our study aimed to establish the complete structure of the main dihydroxy conjugated triene issued from the lipoxygenation (soybean enzyme) of docosahexaenoic acid, named PDX, an isomer of protectin/neuroprotectin D1...
10.
Vericel E, Polette A, Bacot S, Calzada C, Lagarde M
J Thromb Haemost
. 2003 Jul;
1(3):566-72.
PMID: 12871467
n - 3 polyunsaturated fatty acids may protect against vascular diseases, however, their high accumulation in membranes may increase lipid peroxidation and subsequently induce deleterious effects in patients suffering from...